Staff editor

Freya Biosciences secures $10.4 million investment to tackle women’s health challenges

A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.

From Biofarma Group a probiotic therapy as an adjuvant to cancer immunotherapy

Biofarma Group has launched an innovative project in collaboration with the Department of Surgery, Endocrinology and Gastroenterology of the University of Naples ‘Federico II’, the Centro Sperimentale del Latte (CSL)…

QIAGEN and McGill University partner to drive innovation in microbiome research

Three-year collaboration to pioneer new insights in microbial sciences and health applications.

Dietary fiber, bloutia, and mucus function: uncovering potential for Next-Generation Probiotics

The interview with Björn O. Schröder from Umeå University explores groundbreaking research on the gut mucus layer, which shields intestinal tissues from bacterial invasion and inflammation.

EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis treatment

New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.

October 2024 review: M&A, licensing, and investments in one place

October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.

The impact of food additives on the microbiome: pathways to personalized health

Benoit Chassaing from institute Pasteur (France), delves into the ways various environmental factors, particularly dietary additives, affect the gut microbiome. 

Codex Committee on Nutrition and Foods for Special Dietary Uses Concludes 44th Session without Adopting Probiotic Guidelines

In the session's conclusion, CCNFSDU agreed to maintain the status quo for the next three to five years rather than start to work on new guidelines.

Connecting the dots: nutrition, microbiota, metabolism. Key takeaways from Ri.MED Symposium 2024

In a recent Symposium chaired by Giulio Superti-Furga (The Ri.med Foundation), experts gathered to explore groundbreaking research at the intersection of nutrition, microbiota, and human health. 

Artificial intelligence and multi-omic analysis: new frontiers in biomedical research

Microbiomepost conducted an exclusive interview with engineer Corrado Vecchi, representing Ebris, who discussed the role of artificial intelligence (AI) in processing complex data generated from multi-omic studies.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top